Tags

Type your tag names separated by a space and hit enter

Considerations for contraception in women with cardiovascular disorders.
Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):2006-11.AJ

Abstract

Women with hypertension, angina pectoris, or mitral valve prolapse require special considerations when selecting an appropriate method of contraception. All three effective, reversible options (oral contraceptives, intrauterine devices, or progestin implants) carry some degree of added risk for these patient populations. However, pregnancy itself presents certain risks and, in the event of contraceptive failure, certain women with these disorders are at increased risk of developing serious cardiovascular sequelae that affect both mother and fetus. These negative effects can carry far into the neonatal period. This article describes the risk/benefit profiles of the currently available contraceptive options relative to their potential impact in these compromised women.

Authors+Show Affiliations

Division of Cardiovascular Disease, University of Tennessee College of Medicine.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8512045

Citation

Sullivan, J M., and R A. Lobo. "Considerations for Contraception in Women With Cardiovascular Disorders." American Journal of Obstetrics and Gynecology, vol. 168, no. 6 Pt 2, 1993, pp. 2006-11.
Sullivan JM, Lobo RA. Considerations for contraception in women with cardiovascular disorders. Am J Obstet Gynecol. 1993;168(6 Pt 2):2006-11.
Sullivan, J. M., & Lobo, R. A. (1993). Considerations for contraception in women with cardiovascular disorders. American Journal of Obstetrics and Gynecology, 168(6 Pt 2), 2006-11.
Sullivan JM, Lobo RA. Considerations for Contraception in Women With Cardiovascular Disorders. Am J Obstet Gynecol. 1993;168(6 Pt 2):2006-11. PubMed PMID: 8512045.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Considerations for contraception in women with cardiovascular disorders. AU - Sullivan,J M, AU - Lobo,R A, PY - 1993/6/1/pubmed PY - 1993/6/1/medline PY - 1993/6/1/entrez KW - Arterial Occlusive Diseases KW - Arteriosclerosis KW - Atherosclerosis KW - Biology KW - Cardiovascular Effects KW - Contraception KW - Contraceptive Implants KW - Contraceptive Methods KW - Contraceptive Usage KW - Diseases KW - Family Planning KW - Heart Diseases KW - Hypertension--women KW - Iud KW - Literature Review KW - Oral Contraceptives KW - Physiology KW - Pregnancy KW - Recommendations KW - Reproduction KW - Risk Factors KW - Vascular Diseases SP - 2006 EP - 11 JF - American journal of obstetrics and gynecology JO - Am J Obstet Gynecol VL - 168 IS - 6 Pt 2 N2 - Women with hypertension, angina pectoris, or mitral valve prolapse require special considerations when selecting an appropriate method of contraception. All three effective, reversible options (oral contraceptives, intrauterine devices, or progestin implants) carry some degree of added risk for these patient populations. However, pregnancy itself presents certain risks and, in the event of contraceptive failure, certain women with these disorders are at increased risk of developing serious cardiovascular sequelae that affect both mother and fetus. These negative effects can carry far into the neonatal period. This article describes the risk/benefit profiles of the currently available contraceptive options relative to their potential impact in these compromised women. SN - 0002-9378 UR - https://www.unboundmedicine.com/medline/citation/8512045/Considerations_for_contraception_in_women_with_cardiovascular_disorders_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9378(12)90942-4 DB - PRIME DP - Unbound Medicine ER -